Analystreport

Mirum Pharmaceuticals (NASDAQ: MIRM) is now covered by analysts at Raymond James. They set an "outperform" rating and a $28.00 price target on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report